Fluorocurcumins as Cyclooxygenase-2 Inhibitor: Molecular Docking, Pharmacokinetics and Tissue Distribution in Mice

Pharmaceutical Research - United States
doi 10.1007/s11095-009-9955-6
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Molecular Subtype Distribution and Cyclooxygenase-2 Expression Situation in Inflammatory Breast Cancer

Meandros Medical and Dental Journal
2016English

3-Dimensional Quantitative Structure-Activity Relationship and Molecular Docking Studies of Tetrasubstituted Pyrazole Derivatives as Inhibitors of Cyclooxygenase-2

International Journal of Research in Medical Sciences
2014English

Leptin: Its Pharmacokinetics and Tissue Distribution

International Journal of Obesity
NutritionEndocrinologyDieteticsMedicineMetabolismDiabetes
1998English

Molecular Docking and Ligand Specificity in Fragment-Based Inhibitor Discovery

Nature Chemical Biology
Cell BiologyMolecular Biology
2009English

In –Silico Molecular Docking Analysis of Prodigiosin and Cycloprodigiosin as COX-2 Inhibitors

SpringerPlus
Multidisciplinary
2013English

Cytotoxic of Ganoderma Lucidum in Colon Cancer Through Cyclooxygenase 2 (COX-2) as Its Molecular Target

Journal of Tropical Life Science
2017English

The Selective Cyclooxygenase-2 Inhibitor Celecoxib Reduces Bone Resorption, but Not Bone Formation, in Ovariectomized Mice in Vivo

Tohoku Journal of Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
2007English

Molecular Docking of Citronellol, Geraniol and Ester Derivatives as Pim 1 Kinase Inhibitor of Leukemia Cancer

Jurnal Kimia Valensi
2019English

Cyclooxygenase-2-Dependent Prostacyclin Formation and Blood Pressure Homeostasis: Targeted Exchange of Cyclooxygenase Isoforms in Mice

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy